Apple Inc. vs. EVELO BIOSCIENCES INC
Apple Inc. and EVELO BIOSCIENCES INC are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| AAPL | EVLO | |
|---|---|---|
| Market Cap | $4.85 trillion | — |
| Revenue (TTM) | $466.82 billion | — |
| Net Income (TTM) | $128.93 billion | $-82,349,000 |
AAPL leads on 2 of 2 size & scale factors.
Valuation
| AAPL | EVLO | |
|---|---|---|
| P/E Ratio | 38.10 | 0.00 |
| Price / Book | 45.10 | — |
| Price / Sales | 10.39 | — |
EVLO leads on 1 of 1 valuation factors.
Profitability
| AAPL | EVLO | |
|---|---|---|
| Net Margin | 27.62% | — |
| Return on Equity | 119.91% | 308.34% |
EVLO leads on 1 of 1 profitability factors.
Dividend
| AAPL | EVLO | |
|---|---|---|
| Dividend Yield | 0.33% | — |
| Payout Ratio | 12.39 | — |
AAPL and EVLO split the dividend factors evenly.
Risk & Sentiment
| AAPL | EVLO | |
|---|---|---|
| Short Interest | 0.31% | — |
AAPL and EVLO split the risk & sentiment factors evenly.
Dig deeper: AAPL overview, AAPL financials, EVLO overview, EVLO financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.